Medical group M&A activity more than doubled in first quarter of 2017

A new report from Irving Levin Associates and HealthCareMandA.com said mergers and acquisition (M&A) activity “surged” among physician medical groups in the first quarter of the year, with 48 deals confirmed.

The sharp increase is 78 percent above the 28 acquisitions publicly announced in the final quarter of last year and 109 percent above the 23 deals from the first quarter of 2016.

Hospitals and health systems were behind seven of the medical group deals, while private equity firms also announced seven, a figure that doesn’t including transactions involving physician medical groups backed by private equity firms. Nine of the groups acquired in first quarter deals had 20 or more physicians.

“Physicians are quickly realizing that not affiliating with larger entities, whether health systems or large medical groups, is going to make the practice of medicine more difficult in the future,” Lisa Phillips, editor of the Health Care M&A Report, said in a press release.

According to the report, the most prolific buyer was MEDNAX with five acquisitions as part of an early 2017 buying spree. Envision Healthcare acquired four groups, including Sunshine Radiology, while Dermatology Associates and Epiphany Dermatology reported three acquisitions each.

Only one of the deals disclosed the purchase price: the $2.3 billion sale of Surgical Care Affiliates to Optum, a subsidiary of UnitedHealth.  

M&A activity was down in other healthcare sectors. In a separate report, Irving Levin Associates reported a 45 percent year-over-year drop in senior care acquisitions. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”